Marc Drillich Selected Research

Endometritis

1/2021	Messenger RNA Expression of Selected Factors at Different Sites of the Bovine Endometrium Associated With Uterine Health.
10/2020	Field trial on the post-insemination intrauterine treatment of dairy cows with mild endometritis with cephapirin.
5/2017	A review of the ongoing discussion about definition, diagnosis and pathomechanism of subclinical endometritis in dairy cows.
6/2016	Increased mRNA expression of selected pro-inflammatory factors in inflamed bovine endometrium in vivo as well as in endometrial epithelial cells exposed to Bacillus pumilus in vitro.
1/2014	Strategies for the treatment of dairy cows at high risk for postpartum metritis and for the treatment of clinical endometritis in Argentina.
1/2012	Transcriptional response of the bovine endometrium and embryo to endometrial polymorphonuclear neutrophil infiltration as an indicator of subclinical inflammation of the uterine environment.
10/2010	Correlations between periparturient serum concentrations of non-esterified fatty acids, beta-hydroxybutyric acid, bilirubin, and urea and the occurrence of clinical and subclinical postpartum bovine endometritis.
1/2010	Selected pro-inflammatory factor transcripts in bovine endometrial epithelial cells are regulated during the oestrous cycle and elevated in case of subclinical or clinical endometritis.
5/2007	[Subclinical endometritis in dairy cattle and its effect on fertility--a review of recent publications].
4/2005	Treatment of chronic endometritis in dairy cows with an intrauterine application of enzymes. A field trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Drillich Research Topics

Disease

10	Endometritis 01/2021 - 04/2005
2	Necrosis 12/2010 - 01/2010
1	Bacterial Infections (Bacterial Infection) 06/2016
1	Dystocia 01/2014
1	Stillbirth 01/2014
1	Inflammation (Inflammations) 01/2012
1	Vaginal Discharge 04/2005
1	Mastitis 04/2005

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 01/2021 - 01/2010
2	Cephapirin (Cefapirin)FDA Link 10/2020 - 05/2017
2	CytokinesIBA 05/2017 - 06/2016
2	LigandsIBA 06/2016 - 12/2010
2	Prostaglandins FIBA 01/2014 - 04/2005
2	CloprostenolIBA 01/2014 - 04/2005
2	Interleukin-6 (Interleukin 6)IBA 12/2010 - 01/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2010 - 01/2010
2	Interleukin-8 (Interleukin 8)IBA 12/2010 - 01/2010
2	HaptoglobinsIBA 12/2010 - 01/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2007 - 04/2005
2	Peptide Hydrolases (Proteases)FDA Link 05/2007 - 04/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2016
1	CXCR ReceptorsIBA 06/2016
1	ceftiofurIBA 01/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2014
1	Indicators and Reagents (Reagents)IBA 01/2012
1	CXC ChemokinesIBA 12/2010
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2010
1	InterleukinsIBA 12/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2010
1	BilirubinIBA 10/2010
1	Nonesterified Fatty Acids (NEFA)IBA 10/2010
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 10/2010
1	Urea (Carbamide)FDA LinkGeneric 10/2010
1	Chemokine CXCL6IBA 01/2010
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2010
1	DinoprostIBA 05/2007
1	ProstaglandinsIBA 04/2005
1	EnzymesIBA 04/2005